Mary F. Hoult

Mary F. Hoult

No más puestos en curso

58 años
Commercial Services
Health Technology
Consumer Services

Perfil

Ms. Molly Hoult is a Principal at Fletcher Spaght Venture Partners LLC and Independent Director at HTG Molecular Diagnostics, Inc. She is on the Board of Directors at Fletcher Spaght, Inc. and HTG Molecular Diagnostics, Inc. Prior to rejoining the firm in 2009, Ms. Hoult spent over a decade in marketing and business development roles for various biotechnology and medical device firms including: ZymoGenetics, Blue Heron Biotechnology and NeoPath (which subsequently merged to form TriPath and then was acquired by BD Diagnostics).
Ms. Hoult holds an MBA from the Stanford Graduate School of Business and a BA in Biology and Environmental Studies from Dartmouth College.

Antiguos cargos conocidos de Mary F. Hoult.

EmpresasCargoFin
Promidian Inversor de Capital Privado 01/09/2021
Inversor de Capital Privado 01/09/2021
Inversor de Capital Privado 01/04/2019
HTG MOLECULAR DIAGNOSTICS, INC. Director/Miembro de la Junta 01/08/2016
Xcyte Therapies, Inc. Director/Miembro de la Junta -
Ver el detalle de la experiencia de Mary F. Hoult.

Formación de Mary F. Hoult.

Dartmouth College Undergraduate Degree
Stanford Graduate School of Business Masters Business Admin

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Mary F. Hoult.

Relaciones

24

Relaciones de 1er grado

10

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas1
HTG MOLECULAR DIAGNOSTICS, INC.

Commercial Services

Empresas privadas7

Health Technology

Commercial Services

Health Technology

Commercial Services

Xcyte Therapies, Inc.

Health Technology

Promidian

Commercial Services

Ver las conexiones de la empresa
-40% Oferta por Tiempo Limitado: Nuestras suscripciones le guían hacia las mejores inversiones del mañana.
APROVÉCHELO AHORA